Wegovy 2.4 MG/0.75 ML pen 0.75ML
Ended Awarded
- Contract number
- SPE2DB25FRCXT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,555
Award facts
- Contract value 100% obligated
- $18,554.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,554.74 to AmerisourceBergen Drug Corp for the supply of Wegovy 2.4 mg/0.75 mL pens on August 11, 2025, with a completion date of August 12, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award under DLA's pharmaceutical procurement operations. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will fulfill the order from its corporate office location in the same municipality.
This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide. The DLA Troop Support Medical contract encompasses a wide range of medications, vaccines, and medical supplies across multiple therapeutic domains, supporting customers including the Defense Health Agency and the U.S. Coast Guard. This specific delivery order for Wegovy, a diabetes and weight management medication, reflects the ongoing pharmaceutical procurement needs of the federal military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FRCXT?
SPE2DB25FRCXT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 11, 2025.
How much is contract SPE2DB25FRCXT worth?
The government has obligated $18,555 on SPE2DB25FRCXT.
Is contract SPE2DB25FRCXT an order under another contract?
Yes. SPE2DB25FRCXT is a delivery order under SPE2DB25D3008, an indefinite delivery contract.
Was contract SPE2DB25FRCXT competed?
The extent of competition for SPE2DB25FRCXT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award